Claudia Fromond Joins Inventiva as Head of Biology and Pharmacology

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Daix, October 11 2013 – Inventiva, a French biotech company specialized in drug discovery partnerships in addition to developing its own proprietary pipeline, announced today that Dr. Claudia Fromond has joined the company and will be based at Inventiva’s research center in Daix, near Dijon, France. As head of the biology and pharmacology department her responsibilities will include managing the target validation activities, the screening team and the pharmacology group.

Claudia Fromond is a pharmacologist by training with a strong background in the field of cancer, inflammation, immunology and respiratory diseases. After completing her postdoctoral fellowship at Pasteur Institute, she worked for Novartis, Pfizer, Sanofi, Thrombogenics in various senior positions and contributed to the discovery of both NCE and NBE. Claudia has also widely published in highly rated journals including Science, Nature Medicine, Nature Reviews, Clinical Cancer Research, Journal of Clinical Investigation, and Journal of Immunology.

Dr Pierre Broqua, Co-Founder and Chief Scientific Officer of Inventiva, said: «We are extremely pleased to add Claudia to our management team. Her expertise, especially in the field of oncology and auto-immune disorders will be extremely valuable both for our partners and our internal programs

About Inventiva

Inventiva is a drug-discovery company specializing in research partnerships with pharmaceutical firms in diverse therapeutic areas such as Parkinson’s disease, immuno-inflammatory disorders, fibrosis and cancer. Inventiva advances research programs to pre-clinical stage by leveraging its longstanding expertise in nuclear receptors, transcription factors and epigenetics. With a research centre based at Daix, near Dijon (France), Inventiva has more than 90 employees.

For more information on Inventiva, please visit the company’s website: www.inventivapharma.com

Media contacts

Inventiva

Frédéric Cren, CEO

Tel: + 33 (0)3 80 44 75 00

frederic.cren@inventivapharma.com

Brunswick

Benoît Grange

Tel: + 33 (0)1 53 96 83 83

inventiva@brunswickgroup.com

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC